Genovea, Dee-zayr C.

HRN: 27-62-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2025
CEFUROXIME 1.5GM (VIAL)
08/23/2025
08/24/2025
IV
1.5g
Q8 X 2 Doses
S/p Pelvic Lap
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines